Cita APA

Sabatos-Peyton, C. A., Nevin, J., Brock, A., Venable, J. D., Tan, D. J., Kassam, N., . . . Anderson, A. C. (2017). Blockade of Tim-3 binding to phosphatidylserine and CEACAM1 is a shared feature of anti-Tim-3 antibodies that have functional efficacy. Oncoimmunology.

Chicago Style Citation

Sabatos-Peyton, Catherine A., et al. "Blockade of Tim-3 Binding to Phosphatidylserine and CEACAM1 Is a Shared Feature of Anti-Tim-3 Antibodies That Have Functional Efficacy." Oncoimmunology 2017.

Cita MLA

Sabatos-Peyton, Catherine A., et al. "Blockade of Tim-3 Binding to Phosphatidylserine and CEACAM1 Is a Shared Feature of Anti-Tim-3 Antibodies That Have Functional Efficacy." Oncoimmunology 2017.